Worth reading
43Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
100
People (invitation capacity)Wording
Definitive
How definitive the wording is.Announced details
Applicable field (uses covered by this announcement)
IR for bio-related companies
Launch date13 June 2026 (scheduled)
Relationship between the counterparty and the company
Oncolys BioPharma Inc.4588
Relationship with the Company
The company will speak at the IR seminar
CounterpartyNikkei Radio Broadcasting Corporation (Radio NIKKEI)
Organizer of the IR seminar. Other details: not disclosed
Location (as indicated in this announcement)
TKP Garden City Osaka Umeda, 3rd floor, Banquet 3A (3rd floor, TKP Gate Tower Building, 5-4-21 Fukushima, Fukushima-ku, Osaka, Osaka Prefecture)
Capacity: 100 people
Offering price
Participation fee: Free
The company does not address Contract Value / Impact on Business Performance.
| Item | Details |
|---|---|
| Counterparty | Nikkei Radio Broadcasting Corporation (Radio NIKKEI) |
| Counterparty overview | Organizer of the IR seminar. Other details: not disclosed |
| Relationship with the Company | The company will speak at the IR seminar |
| Offering price | Participation fee: Free |
| Launch date | 13 June 2026 (scheduled) |
| Applicable area | IR for bio-related companies |
| Location | TKP Garden City Osaka Umeda, 3rd floor, Banquet 3A (3rd floor, TKP Gate Tower Building, 5-4-21 Fukushima, Fukushima-ku, Osaka, Osaka Prefecture) |
| Location scale | Capacity: 100 people |
Items this document does not state (10)
Names of Products / Services CoveredContract ValueContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateQuantitative EffectsUsage historyImpact on Business PerformanceSource
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Not disclosed
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.